FORTAZ is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teligent Pharma, Inc.. The primary component is Ceftazidime.
| Product ID | 52565-113_da2c70ba-ae63-494a-88d7-082b32ab4f7c |
| NDC | 52565-113 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FORTAZ |
| Generic Name | Ceftazidime Sodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2013-04-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050634 |
| Labeler Name | Teligent Pharma, Inc. |
| Substance Name | CEFTAZIDIME |
| Active Ingredient Strength | 40 mg/mL |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2016-10-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050634 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-10-19 |
| Marketing End Date | 2019-09-12 |
| Ingredient | Strength |
|---|---|
| CEFTAZIDIME | 40 mg/mL |
| SPL SET ID: | 78982c98-7866-49f1-989f-a289c4242358 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52565-105 | FORTAZ | ceftazidime |
| 52565-106 | FORTAZ | ceftazidime |
| 52565-107 | FORTAZ | ceftazidime |
| 52565-109 | FORTAZ | ceftazidime |
| 52565-110 | FORTAZ | ceftazidime |
| 52565-111 | FORTAZ | ceftazidime |
| 52565-112 | FORTAZ | ceftazidime sodium |
| 52565-113 | FORTAZ | ceftazidime sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FORTAZ 73376990 1286762 Live/Registered |
Glaxo Group Limited 1982-07-28 |